Refine your search
Sort By Date Sector- Banks (16)
- Consumer goods & retail (25)
- Energy & infrastructure (18)
- Investment management (10)
- Government & public policy (14)
- Healthcare, life sciences & chemicals (67)
- Industrials (27)
- Insurance (13)
- Private equity (13)
- Real estate (12)
- Technology, media & telecoms (24)
- Transport & logistics (19)
- Results 1-10 of 67
-
Publication of a new decree related to the law n°2011-2012 of 29 December 2011 improving the safety of medicines and health products ('Transparency law')
23 May 2013PublicationThe long-awaited decree was issued on 21 May 2013 (the "Decree"). The Decree enables the implementation of the Transparency Law. A circular which will provide complete terms and conditions of application of the Decree should also be published...
-
China Publishes Revised Good Supply Practice (GSP) Standards for Pharmaceutical Products
20 May 2013PublicationAfter several years of drafting and three rounds of public consultation, the Ministry of Health has at last published the revised Good Supply Practice for Pharmaceutical Products (Revised GSP Standards) (药品经营质量管理规范) on 22 January 2013. The Revised GSP Standards...
-
Foreign investment regulation in Australia
16 May 2013PublicationAustralia continues to be the destination of a significant volume of foreign direct investment, and has been ranked within the top 10 most attractive locations for foreign investment globally. Foreign investment in Australia is governed by a complex combination...
-
Another step towards a unitary European patent
12 April 2013PublicationThe Unitary patent package Twenty-five member states of the European Union, including the Czech Republic and Slovakia recently signed an Agreement on a Unified Patent Court ("UPC"). The agreement (if ratified by the required number of participating...
-
OFT clarifies its approach to review of NHS mergers
26 March 2013PublicationOn 22 March 2013 the OFT published a "Frequently Asked Questions" document setting out further details on its remit and role in respect of National Health Service ("NHS") mergers. Notably, the FAQ highlight the OFT's broad remit...
-
Verhalten bei Ermittlungen der Europäischen Kommission oder des Bundeskartellamtes
20 March 2013PublicationAllgemeine Vorbereitung Die folgenden Maßnahmen sollten zur allgemeinen Vorbereitung für den Fall einer Vor-Ort-Nachprüfung oder Durchsuchung durch Kartellbehörden getroffen werden: 1. Erstellen Sie eine Liste der Mitglieder der Geschäftsleitung...
-
New Australian pharmaceutical code increases reporting - with more to come
14 March 2013PublicationOn 20 December 2012, the Australian Competition and Consumer Commission (ACCC) authorised edition 17 of Medicines Australia’s Code of Conduct (MACC) for two years only. Medicines Australia had sought authorisation for five years. The MACC is a voluntary...
-
Newsletter - Patent Law Series 'EU patent - almost there?'
24 January 2013PublicationAfter years of deliberations, the so-called "EU package" was approved by the European Parliament and Council in December 2012. While it remains to be seen whether the legislative acts of the highly contentious package will really come into force as...
-
Observations on the M&A Strategies of Multinationals in China's Pharmaceutical Market in 2012
8 January 2013PublicationRecent years have seen acquisitions become a common element of any growth strategy for multinationals engaged in China's pharmaceutical market. At least half of the top 10 multinationals in China appear to be actively pursuing one or more targets with...
-
Germany: Control of Foreign Investments
18 December 2012PublicationThe German Foreign Trade Act (Außenwirtschaftsgesetz) and the respective implementation regulation (Außenwirtschaftsverordnung) enable the German federal government to prohibit or restrict certain foreign investments in Germany. This form of acquisition...

